0KSX Stock Overview
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 5/6 |
Quest Diagnostics Incorporated Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$128.28 |
52 Week High | US$147.55 |
52 Week Low | US$119.84 |
Beta | 0.90 |
1 Month Change | 1.61% |
3 Month Change | -6.39% |
1 Year Change | -8.50% |
3 Year Change | 1.38% |
5 Year Change | 43.88% |
Change since IPO | 20.32% |
Recent News & Updates
Recent updates
Shareholder Returns
0KSX | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0.6% | -0.5% | 2.4% |
1Y | -8.5% | -20.9% | 4.2% |
Return vs Industry: 0KSX exceeded the UK Healthcare industry which returned -21.2% over the past year.
Return vs Market: 0KSX underperformed the UK Market which returned 4.9% over the past year.
Price Volatility
0KSX volatility | |
---|---|
0KSX Average Weekly Movement | 2.5% |
Healthcare Industry Average Movement | 7.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0KSX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0KSX's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 44,000 | Jim Davis | https://www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
0KSX fundamental statistics | |
---|---|
Market cap | US$14.31b |
Earnings (TTM) | US$850.00m |
Revenue (TTM) | US$9.25b |
16.8x
P/E Ratio1.5x
P/S RatioIs 0KSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0KSX income statement (TTM) | |
---|---|
Revenue | US$9.25b |
Cost of Revenue | US$6.18b |
Gross Profit | US$3.07b |
Other Expenses | US$2.22b |
Earnings | US$850.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 23, 2024
Earnings per share (EPS) | 7.68 |
Gross Margin | 33.17% |
Net Profit Margin | 9.19% |
Debt/Equity Ratio | 75.3% |
How did 0KSX perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield37%
Payout RatioDoes 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarksQuest Diagnostics dividend dates | |
---|---|
Ex Dividend Date | Apr 05 2024 |
Dividend Pay Date | Apr 22 2024 |
Days until Ex dividend | 10 days |
Days until Dividend pay date | 27 days |
Does 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarks